Skinhealth Systems Inc. · NASDAQ:SKIN
Skinhealth Systems — Q1 2025 Earnings Presentation
18 slides from Skinhealth Systems's earnings presentation, May 8, 2025
Slide 1: First Quarter 2025 Earnings Presentation
First Quarter 2025 Earnings Presentation May 8, 2025
Slide 2: Disclaimer
Disclaimer This Presentation contains certain forward-looking statements. These statements may relate to, but are not limited to, expectations of future operating results or financial performance of The Beauty Health Company (the "Company"), capital expenditures, the introduction of new products, ma
Slide 3: Hydrafacial is a Medtech Meets Beauty company
Beauty Hydrafacial is a Medtech Meets Beauty company at the nexus Aesthetics Wellness of Beauty, Aesthetics, Wellness and Health Health
Slide 4: Q1 2025 Performance Update
ae BEAUTYHEALTH y- Q1 2025 ‘a Performance Update
Slide 5: First Quarter 2025 Highlights
First Quarter 2025 Highlights Delivery Systems Consumables Adjusted Net Sales Net Income (Loss) 1 Net Sales Net Sales EBITDA $69.6m $20.2m $49.4m $(10.1)m $7.3m -14.5% YoY -43.5% YoY +8.2% YoY -$9.4m YoY +$6.9m YoY Lower delivery systems Decrease in delivery Continued year-over-year The decrease was
Slide 6: 2025 Strategic Focus
2025 Strategic Focus Enhancing Commercial Accelerating Science- Deepening Provider Execution Backed Innovation Partnerships Refining our pricing model, Expanding our booster Increasing engagement, increasing lead conversion, pipeline, skincare offerings, simplifying sales execution, and strengthenin
Slide 7: Transformative Progress Under New Leadership
Transformative Progress Under New Leadership Appointed new Chief Supply Chain & Operations Officer to improve operations Re-aligned manufacturing capacity to improve gross margins; concluded China third-party manufacturing by OPERATIONAL consolidating global manufacturing operations at our facility
Slide 8: Updated 2025 Financial Guidance
Updated 2025 Financial Guidance 2Q 2025 FY 2025 $71 – $76m $270 – $300m 2Q 2025E net sales FY 2025E net sales $2 – $4m $15 – $25m 2Q 2025E adjusted EBITDA1 FY 2025E adjusted EBITDA1 8 1. Adjusted EBITDA is a non-GAAP measure; please refer to the disclaimer for a discussion of the definition of this
Slide 9: Compelling Business Model
Compelling Business Model Harnessing the power of our large device footprint and clinically effective consumables device footprint 9
Slide 10: Strongly Positioned in Growing Industry
Strongly Positioned in Growing Industry Our Opportunity Our Leadership 7% #1 global medical aesthetic market projected growth through 20291 Market Share 2 41% #2 of aesthetic practices with microdermabrasion offer Hydrafacial Best-Known Brand 3 treatments currently2 75% 1.5 of consumers agree their
Slide 11: Positioned for Long-Term Success
Positioned for Long-Term Success DIFFERENTIATED LOYAL LEADER IN LARGE, ESTHETICIANS PRODUCT & ADDRESSABLE TECHNOLOGY MARKET Adored by estheticians for attractive economics, Created hydradermabrasion rapid equipment Omnichannel distribution and category with clinical favorable global tailwinds paybac
Slide 12: Anchored by our flagship brand, Hydrafacial
Anchored by our Asked for by name and flagship brand, Hydrafacial recommended to friends 39% Brand 96% RealSelf awareness1 “Worth It” Rating3 55% more 52 Consumer conversion Net than Promoter Botox1 Score2 12 1. Ipsos Study. July 2024. Base: Consumers of the aesthetic and professional beauty categor
Slide 13: Hydrafacial continues to drive revenue for providers
Hydrafacial continues to drive An esthetician performing revenue for just 10 Hydrafacial treatments per week can earn providers 1-in-5 aesthetics consumers have received a Hydrafacial $100,000 The typical Hydrafacial client purchases more than one treatment1 annually2 aesthetic treatment per month1
Slide 14: Clinically Proven Immediate and Long-Term Results
Clinically Proven Immediate and Long-Term Results In clinical studies with participants ranging in skin types and concerns After just 1 treatment1 Pore size 100% of participants reported decreased pore size Fine lines Statistically 90% of participants reported significant decreased visible fine line
Slide 15: Skin Health Benefits Beyond the Face: Hydrafacial Keravive treatments
Skin Health Benefits Beyond the Face: Hydrafacial Keravive treatments First-of-its-kind scalp facial powered by Hydrafacial’s patented Vortex Technology The three-step, in-office treatment and at-home regimen is designed to deeply cleanse, exfoliate, and nourish the scalp THE SKINIFICATION OF THE SC
Slide 16: Appendix: Non-GAAP Financial Reconciliations
Appendix: Non-GAAP Financial Reconciliations
Slide 17: First Quarter 2025 Non-GAAP Financial Reconciliations
First Quarter 2025 Non-GAAP Financial Reconciliations Reconciliation of net loss to adjusted EBITDA Reconciliation of gross profit to adjusted gross profit Three Months Ended Three Months Ended March 31, March 31, Unaudited ($ in millions) 1 2025 2024 Unaudited ($ in millions) 1 2025 2024 Net sales
Slide 18: BEAUTYHEALTH
+ BEAUTYHEALTH